SCHEMBL6032037

SCHEMBL6032037

CC1(C)CC(=O)C2=C(C1)NC(C1CC1)=C(C(=O)O)C2C1CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.48
GSK3B P49841 2/20 0.48
ALDH1A1 P00352 8/20 0.44
KDM4E B2RXH2 4/20 0.44
GAA P10253 3/20 0.44
GLA P06280 1/20 0.44
HTT P42858 2/20 0.42
NCOA1 Q15788 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
HPGD P15428 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CACNA1D Q01668 1/20 0.36
TSHR P16473 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 2/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6027988 0.83 TSHR (0.52) GSK3AGSK3BALDH1A1KDM4EGAA
SCHEMBL6028433 0.79 HTT (0.54) GSK3AGSK3BALDH1A1KDM4EGAA
SCHEMBL10038008 0.74 ALDH1A1 (0.41) GSK3AGSK3BALDH1A1KDM4EGAA
SCHEMBL6027946 0.73 KDM4E (0.56) GSK3AGSK3BALDH1A1KDM4EGAA
SCHEMBL4578818 0.73 CETP (0.44) GSK3AMEN1KMT2A
SCHEMBL713237 0.72 CETP (0.44) GSK3AMEN1KMT2A
SCHEMBL5816033 0.71 KDM4E (0.58) GSK3AGSK3BALDH1A1KDM4EGAA
SCHEMBL5821977 0.69 NPSR1 (0.53) GSK3AGSK3BALDH1A1KDM4EGAA
SCHEMBL6028459 0.68 EGFR (0.58) GSK3AGSK3BALDH1A1KDM4EGAA
SCHEMBL6461742 0.68 ALDH1A1 (0.68) GSK3AGSK3BALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663227-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS Synta Pharmaceuticals Corporation (US) 2006-06-07 EP disclosed
WO-2005025507-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS SYNTA PHAMACEUTICALS CORP. (US) 2005-03-24 WO disclosed